FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 71506-017 | 71506-017-59 | Vancomycin Hydrochloride | Vancomycin Hydrochloride | 1.75 g/500 mL | 2026-1 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-174 | 63037-174-25 | Phenylephrine Hydrochloride | .5 mg/5 mL | 2026-1 | valid | 2026-10-06 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-173 | 63037-173-25 | Phenylephrine Hydrochloride | 1 mg/10 mL | 2026-1 | valid | 2026-10-06 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-155 | 63037-155-25 | Rocuronium Bromide | 50 mg/5 mL | 2026-1 | valid | 2026-10-06 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-156 | 63037-156-25 | Rocuronium Bromide | 100 mg/10 mL | 2026-1 | valid | 2026-10-06 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-119 | 63037-119-05 | Diltiazem Hydrochloride | 125 mg/125 mL | 2026-1 | valid | 2026-10-06 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-119 | 63037-119-10 | Diltiazem Hydrochloride | 125 mg/125 mL | 2026-1 | valid | 2026-10-06 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-117 | 63037-117-05 | Diltiazem Hydrochloride | 125 mg/125 mL | 2026-1 | valid | 2026-10-06 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-117 | 63037-117-10 | Diltiazem Hydrochloride | 125 mg/125 mL | 2026-1 | valid | 2026-10-06 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-123 | 63037-123-25 | Ephedrine Sulfate | 50 mg/5 mL | 2026-1 | valid | 2026-10-06 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-136 | 63037-136-25 | Ketamine Hydrochloride | 50 mg/5 mL | 2026-1 | valid | 2026-10-06 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-137 | 63037-137-25 | Ketamine Hydrochloride | 50 mg/1 mL | 2026-1 | valid | 2026-10-06 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-164 | 63037-164-25 | Lidocaine Hydrochloride Anhydrous | 100 mg/5 mL | 2026-1 | valid | 2026-10-06 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-139 | 63037-139-25 | Neostigmine Methylsulfate | 5 mg/5 mL | 2026-1 | valid | 2026-10-06 | |
| Hikma Injectables USA Inc. | 63037-117 | 63037-117-05 | Diltiazem HCl | Diltiazem HCl | 125 mg/125 mL | 2026-1 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-117 | 63037-117-10 | Diltiazem HCl | Diltiazem HCl | 125 mg/125 mL | 2026-1 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-119 | 63037-119-05 | Diltiazem HCl | Diltiazem HCl | 125 mg/125 mL | 2026-1 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-119 | 63037-119-10 | Diltiazem HCl | Diltiazem HCl | 125 mg/125 mL | 2026-1 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-123 | 63037-123-25 | Ephedrine Sulfate | Ephedrine Sulfate | 50 mg/5 mL | 2026-1 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-100 | 63037-100-10 | Fentanyl Citrate in 0.9 % Sodium Chloride | Fentanyl Citrate in 0.9% Sodium Chloride Injection | 1000 ug/100 mL | 2026-1 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-101 | 63037-101-10 | Fentanyl Citrate in 0.9% Sodium Chloride | Fentanyl Citrate in 0.9% Sodium Chloride Injection | 2500 ug/250 mL | 2026-1 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-136 | 63037-136-25 | Ketamine HCl | Ketamine HCl | 50 mg/5 mL | 2026-1 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-137 | 63037-137-25 | Ketamine HCl | Ketamine HCl | 50 mg/1 mL | 2026-1 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-164 | 63037-164-25 | Lidocaine HCl | Lidocaine HCl 2% | 100 mg/5 mL | 2026-1 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-198 | 63037-198-01 | Morphine Sulfate | Morphine Sulfate | 100 mg/100 mL | 2026-1 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-139 | 63037-139-25 | Neostigmine Methylsulfate | Neostigmine Methylsulfate | 5 mg/5 mL | 2026-1 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-173 | 63037-173-25 | Phenylephrine HCl | Phenylephrine HCl | 1 mg/10 mL | 2026-1 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-174 | 63037-174-25 | Phenylephrine HCl | Phenylephrine HCl | .5 mg/5 mL | 2026-1 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-156 | 63037-156-25 | Rocuronium Bromide | Rocuronium Bromide | 100 mg/10 mL | 2026-1 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-155 | 63037-155-25 | Rocuronium Bromide | Rocuronium Bromide | 50 mg/5 mL | 2026-1 | valid | 2026-09-18 | |
| Hikma Pharmaceuticals USA Inc. | 946499746 | 63037-101 | 63037-101-10 | Fentanyl Citrate | 2500 ug/250 mL | 2026-1 | valid | 2026-10-06 | |
| Hikma Pharmaceuticals USA Inc. | 946499746 | 63037-100 | 63037-100-10 | Fentanyl Citrate | 1000 ug/100 mL | 2026-1 | valid | 2026-10-06 | |
| Hikma Pharmaceuticals USA Inc. | 946499746 | 63037-198 | 63037-198-01 | Morphine Sulfate | 100 mg/100 mL | 2026-1 | valid | 2026-10-06 | |
| Hybrid Pharma | 079665742 | 26436-5473 | 26436-5473-3 | Benzocaine; Tetracaine; Lidocaine | 200 mg/1 g; 20 mg/1 g; 80 mg/1 g | 2026-1 | valid | 2026-10-06 | |
| Hybrid Pharma | 079665742 | 26436-5429 | 26436-5429-2 | Benzocaine; Tetracaine; Lidocaine | 200 mg/1 g; 40 mg/1 g; 60 mg/1 g | 2026-1 | valid | 2026-10-06 | |
| Hybrid Pharma | 079665742 | 26436-5200 | 26436-5200-3 | Benzocaine; Tetracaine; Lidocaine | 200 mg/1 g; 40 mg/1 g; 60 mg/1 g | 2026-1 | valid | 2026-10-06 | |
| Hybrid Pharma | 079665742 | 26436-5200 | 26436-5200-4 | Benzocaine; Tetracaine; Lidocaine | 200 mg/1 g; 40 mg/1 g; 60 mg/1 g | 2026-1 | valid | 2026-10-06 | |
| Hybrid Pharma | 079665742 | 26436-5473 | 26436-5473-1 | Benzocaine; Tetracaine; Lidocaine | 200 mg/1 g; 20 mg/1 g; 80 mg/1 g | 2026-1 | valid | 2026-10-06 | |
| Hybrid Pharma | 079665742 | 26436-6028 | 26436-6028-3 | Procaine Hydrochloride | 20 mg/1 mL | 2026-1 | valid | 2026-10-06 | |
| Hybrid Pharma | 079665742 | 26436-5152 | 26436-5152-1 | Progesterone | 150 mg | 2026-1 | valid | 2026-10-06 | |
| Hybrid Pharma | 079665742 | 26436-5248 | 26436-5248-1 | Progesterone | 125 mg | 2026-1 | valid | 2026-10-06 | |
| Hybrid Pharma | 079665742 | 26436-5002 | 26436-5002-1 | Pyridoxine Hydrochloride | 100 mg/1 mL | 2026-1 | valid | 2026-10-06 | |
| Hybrid Pharma | 079665742 | 26436-5471 | 26436-5471-3 | Riboflavin 5'-Phosphate Sodium; Niacinamide; Pyridoxine Hydrochloride; Thiamine Hydrochloride | 2 mg/1 mL; 100 mg/1 mL; 2 mg/1 mL; 100 mg/1 mL | 2026-1 | valid | 2026-10-06 | |
| Hybrid Pharma | 079665742 | 26436-5635 | 26436-5635-5 | Semaglutide | 5 mg/1 mL | 2026-1 | valid | 2026-10-06 | |
| Hybrid Pharma | 079665742 | 26436-5608 | 26436-5608-2 | Semaglutide | 2.5 mg/1 mL | 2026-1 | valid | 2026-10-06 | |
| Hybrid Pharma | 079665742 | 26436-5647 | 26436-5647-2 | Sermorelin Acetate | 350 ug | 2026-1 | valid | 2026-10-06 | |
| Hybrid Pharma | 079665742 | 26436-5424 | 26436-5424-2 | Sermorelin Acetate | 300 ug | 2026-1 | valid | 2026-10-06 | |
| Hybrid Pharma | 079665742 | 26436-0001 | 26436-0001-1 | Sildenafil Citrate | 100 mg | 2026-1 | valid | 2026-10-06 | |
| Hybrid Pharma | 079665742 | 26436-5613 | 26436-5613-1 | Tadalafil | 12 mg | 2026-1 | valid | 2026-10-06 | |
| Hybrid Pharma | 079665742 | 26436-0059 | 26436-0059-2 | Tadalafil | 20 mg | 2026-1 | valid | 2026-10-06 |